Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Kelly

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
The Journal of Clinical Investigation|August 1, 1991
Effector mechanisms in organ-specific autoimmunity. I. Characterization of a CD8+ T cell line that mediates murine interstitial nephritisC M Meyers, C J Kelly
Seminars in Nephrology|May 5, 1999
Nitric oxide in interstitial nephritis and other autoimmune diseasesC J Kelly, D P Gold
Current Opinion in Ophthalmology|July 1, 1999
Ocular manifestations of pediatric diseaseC J Kelly, J H Calhoun
The Journal of Clinical Investigation|November 1, 1994
Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factorC M Meyers, C J Kelly
Kidney International|November 1, 1994
Immunoregulation and TGF-beta 1. Suppression of a nephritogenic murine T cell cloneC M Meyers, C J Kelly
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1987
Medullary cystic disease: an inherited form of autoimmune interstitial nephritis?C J Kelly, E G Neilson
Current Pharmaceutical Design|July 29, 2004
The therapeutic role of taurine in ischaemia-reperfusion injuryR Kingston, C J Kelly, P Murray
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1988
The selection of effector T cell phenotype by contrasuppression modulates susceptibility to autoimmune injuryC J Kelly, H Mok, E G Neilson
Human Reproduction Update|July 17, 2010
Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysisC J Kelly, S R Stenton, H Lashen
Irish Journal of Medical Science|March 31, 1999
Thoracoscopic Hellers myotomy for oesophageal achalasiaS Rea, C J Kelly, P J Broe
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
The Journal of Clinical Investigation|August 1, 1991
Effector mechanisms in organ-specific autoimmunity. I. Characterization of a CD8+ T cell line that mediates murine interstitial nephritisC M Meyers, C J Kelly
Seminars in Nephrology|May 5, 1999
Nitric oxide in interstitial nephritis and other autoimmune diseasesC J Kelly, D P Gold
Current Opinion in Ophthalmology|July 1, 1999
Ocular manifestations of pediatric diseaseC J Kelly, J H Calhoun
The Journal of Clinical Investigation|November 1, 1994
Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factorC M Meyers, C J Kelly
Kidney International|November 1, 1994
Immunoregulation and TGF-beta 1. Suppression of a nephritogenic murine T cell cloneC M Meyers, C J Kelly
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1987
Medullary cystic disease: an inherited form of autoimmune interstitial nephritis?C J Kelly, E G Neilson
Current Pharmaceutical Design|July 29, 2004
The therapeutic role of taurine in ischaemia-reperfusion injuryR Kingston, C J Kelly, P Murray
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1988
The selection of effector T cell phenotype by contrasuppression modulates susceptibility to autoimmune injuryC J Kelly, H Mok, E G Neilson
Human Reproduction Update|July 17, 2010
Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysisC J Kelly, S R Stenton, H Lashen
Irish Journal of Medical Science|March 31, 1999
Thoracoscopic Hellers myotomy for oesophageal achalasiaS Rea, C J Kelly, P J Broe
Pageof 16